ESC Premium Access

Atrial fibrillation ablation: stroke and bleeding

Event: ESC Congress 2018
Topic: Pathophysiology and Mechanisms
Session type: Symposium
Date: 27 August 2018
Time: 14:30 - 15:45

Session

4 presentations in this session

Continuous vs. interrupted anticoagulation for atrial fibrillation ablation patients - what do the data tell us?

Speaker: Professor L. Di Biase (The Bronx, US)
Thumbnail

Silent brain lesions and clinically relevant bleeds - the next frontiers for making atrial fibrillation ablation safer.

Speaker: Professor L. Mont (Barcelona, ES)
Thumbnail

Who should be considered for left atrial appendage occlusion in the era of direct anticoagulants?

Speaker: Professor M. Glikson (Jerusalem, IL)
Thumbnail

The key question: can anticoagulation be abandoned after catheter ablation of atrial fibrillation?

Speaker: Doctor A. Verma (Montreal, CA)
Thumbnail

4 speakers from this session

Professor Luigi Di Biase

Albert Einstein College of Medicine at Montefiore Hospital, The Bronx (United States of America)
20 presentations
0 follower

Professor Lluis Mont

Hospital Clinic, University of Barcelona, Barcelona (Spain)
19 presentations
0 follower

Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)
14 presentations
0 follower

Doctor Atul Verma

McGill University Health Centre, Montreal (Canada)
6 presentations
0 follower

This platform is supported by

logo Novo Nordisk